share_log

Femasys | 4: Statement of changes in beneficial ownership of securities-Officer Thomas Christine E

SEC announcement ·  Feb 2 16:48
Summary by Moomoo AI
Christine E. Thomas, SVP of Regulatory & Clinical at Femasys Inc. (FEMY.US), was reported to have engaged in a transaction involving the company's stock on February 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Femasys and its potential impact on the stock's performance.
Christine E. Thomas, SVP of Regulatory & Clinical at Femasys Inc. (FEMY.US), was reported to have engaged in a transaction involving the company's stock on February 1, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. This information is critical for investors to understand the insider activity within Femasys and its potential impact on the stock's performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more